Education
About Us
Working with TipRanks
Follow Us
Mochida Pharmaceutical Co., Ltd. (DE:MFY)
FRANKFURT:MFY
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 105.16B | ¥ 102.89B | ¥ 103.26B | ¥ 110.18B | ¥ 103.00B |
| Gross Profit | ¥ 53.79B | ¥ 52.07B | ¥ 55.12B | ¥ 59.55B | ¥ 54.79B |
| Operating Income | ¥ 8.13B | ¥ 5.80B | ¥ 8.51B | ¥ 14.39B | ¥ 12.00B |
| EBITDA | ¥ 11.00B | ¥ 8.97B | ¥ 11.71B | ¥ 17.28B | ¥ 14.75B |
| Net Income | ¥ 5.68B | ¥ 4.55B | ¥ 6.65B | ¥ 10.57B | ¥ 8.59B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 51.15B | ¥ 46.79B | ¥ 60.51B | ¥ 61.91B | ¥ 63.49B |
| Total Assets | ¥ 160.12B | ¥ 158.80B | ¥ 158.83B | ¥ 163.14B | ¥ 161.79B |
| Total Debt | ¥ 342.00M | ¥ 369.00M | ¥ 190.00M | ¥ 0.00 | ¥ 0.00 |
| Net Debt | ¥ -45.15B | ¥ -33.29B | ¥ -46.82B | ¥ -48.41B | ¥ -54.49B |
| Total Liabilities | ¥ 29.43B | ¥ 30.83B | ¥ 32.06B | ¥ 34.50B | ¥ 34.82B |
| Stockholders' Equity | ¥ 130.69B | ¥ 127.97B | ¥ 126.77B | ¥ 128.64B | ¥ 126.97B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 7.19B | ¥ -9.78B | ¥ 5.13B | ¥ 4.36B | ¥ 7.11B |
| Operating Cash Flow | ¥ 9.35B | ¥ -7.48B | ¥ 7.30B | ¥ 7.46B | ¥ 9.20B |
| Investing Cash Flow | ¥ 17.36B | ¥ 74.00M | ¥ -2.95B | ¥ -2.01B | ¥ -880.00M |
| Financing Cash Flow | ¥ -2.87B | ¥ -6.39B | ¥ -6.88B | ¥ -5.96B | ¥ -5.11B |